NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 18 November 2008

Recipharm moves into biologics manufacturing

Recipharm's biotech subsidiary, Recipharm Biotech, has acquired AstraZeneca's biotech manufacturing facility in Södertälje, Sweden. AstraZeneca has entered a supply arrangement with Recipharm for Phase I and Phase II material for one of its development projects and will hold a significant minority stake in the new company.
Recipharm

No comments: